Position in TNXP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$238,216
-$49,848 QoQ
Shares Held
18,669
+1.2% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 103 holders
Holding Since
Jun 2022
4 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in TNXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,100,351,284 across 114 Biotechnology names. TNXP ranks #106 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in TNXP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,216 | 18,669 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $288,064 | 18,442 | Shares | Defined | 2026-02-17 | |
| 2022-09-30 | $14,170 | 26,736 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,305 | 10,320 | Principal | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||